Headlines
-
Biologics and barcodes
Thursday | Jan 25 2018THE Therapeutic Goods Administration (TGA) has published 34 submissions to its 'Nomenclature of biological medicines' consultation.
-
‘Consumers are winners’
Wednesday | Jan 24 2018THE Australian Self Medication Industry (ASMI) has touted consumers as "winners" from the Therapeutic Goods Administration's (TGA's) proposed advertising reform (PD 19 Jan) and new approach to increasing availability of pharmacist-only medicines.
-
CMA blasts ‘fringe’ groups
Tuesday | Jan 23 2018COMPLEMENTARY Medicines Australia (CMA) has criticised Friends of Science in Medicine and health activist Ken Harvey, (PD yesterday)describing him as "disingenuous" on the subject of advertising pre-approvals.
-
Dose Innovations administration
Tuesday | Jan 23 2018EXTERNAL administrators have been appointed to Brisbane-based Dose Innovations Pty Ltd, which distributes the Rowa Automated Dispensary system endorsed by the Pharmacy Guild's Gold Cross Products & Services in 2015.
-
API warns of slow sales
Monday | Jan 22 2018AUSTRALIAN Pharmaceutical Industries this morning alerted investors that its half year result would be down about 9% on the previous corresponding period, with "suppressed retail conditions" persisting until late in the key Christmas trading period.
-
Concern over CM ad changes
Monday | Jan 22 2018THE Federal government has been accused of attempting to bypass a Senate Committee review of proposed changes to advertising of complementary medicines, on the basis that the Therapeutic Goods Amendment Bill is "non-controversial".
-
S3 advertising permitted
Friday | Jan 19 2018THE Therapeutic Goods Administration has confirmed that the advertising of Schedule 3 (Pharmacist Only) medicines is to be allowed, along with the implementation of a more timely "switch" process facilitating rescheduling of Schedule 4 medicines to S3 and/or S2.
-
Codeine story ‘misleading’
Friday | Jan 19 2018WHILE the rescheduling of products containing codeine has been based mainly on the fact that codeine can cause dependence, and its misuse has led to addiction and even death, it is "misleading" to argue that withdrawing the products from OTC sale will reduce codeine use, according to University of Sydney Honorary Professor of Pharmacology Peter Carroll (pictured).
-
SHPA affirms codeine move
Thursday | Jan 18 2018THE Society of Hospital Pharmacists of Australia has recommitted its support for the rescheduling of OTC codeine products, which will become prescription only from 01 Feb 2018.
-
PSA seals diabetes deal
Wednesday | Jan 17 2018THE Pharmaceutical Society of Australia (PSA) has signed a new Memorandum of Understanding with the Australian Diabetes Educators Association (ADEA).